Praxis Precision Medicines, Inc. (PRAX) stock analysis
In our weekly check, Praxis Precision Medicines, Inc. is graded F (A to F). Of 18 checks on debt, profit, cash flow and trend: 5 pass, warnings: 4, red flags: 9.
About Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as PRAX.
What our checks show for PRAX
Red flags
- Earnings per share fell 43% a year over the last 3 years.
- The company has no revenue yet.
- Free cash flow is negative and the company has no revenue yet: it lives on its cash and new funding.
- The price swings a lot: 72.9% annual volatility. Expect large ups and downs.
- The stock has fallen as much as 99% from a peak. Would you have held through that?
- Beta 2.84: the stock usually moves more than the market, both up and down.
- The share count grew by 241% in 2 years: each shareholder owns a smaller slice.
- Return on capital (ROCE) is zero or negative: the business does not earn on the money put into it.
- Free cash flow is negative, so no cash is left over to cover pay in shares.
Warning signs
- Operating cash flow is negative while the company reports a profit: the profit does not arrive as cash.
- Analysts expect earnings per share to shrink about 31.3% a year.
- The stock is still below its previous peak.
- Thinly traded (about 460 thousand shares a day): buying and selling can move the price.
Strengths
- Debt is low: 0x equity.
- Analysts expect the net margin to improve by 20.9 points from today's 0%.
Similar companies
KRYS · TGTX · PTGX · SYRE · MDGL · PCVX
Questions
What grade does Praxis Precision Medicines, Inc. (PRAX) have?
In our weekly check, Praxis Precision Medicines, Inc. is graded F (A to F). Of 18 checks on debt, profit, cash flow and trend: 5 pass, warnings: 4, red flags: 9. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of PRAX stock?
This week's biggest flags for Praxis Precision Medicines, Inc.: Weak EPS growth, Thin margins, Weak free cash flow. In total 13 of 18 checks show a warning or a red flag.
What does Praxis Precision Medicines, Inc. do?
Praxis Precision Medicines, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as PRAX.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis